BOSTON, MA / ACCESSWIRE / January 24, 2023 / Block & Leviton is investigating Surmodics, Inc. (NASDAQ:SRDX) for potential securities law violations. Investors who have lost money in their Surmodics investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://www.blockleviton.com/cases/srdx.
What is this all about?
Before the market opened on January 19, 2023, Surmodics announced receipt of a letter from the U.S. Food & Drug Administration (FDA), indicating that the Company's pre-market approval application for its Surveil drug-coated balloon is not currently approvable. The FDA letter noted the need for additional information regarding biocompatibility and labeling.
Shares of Surmodics, Inc. stock dropped more than 25% in intraday trading on January 19, 2023.
Who is eligible?
Anyone who purchased Surmodics, Inc. stock and has lost money may be eligible, whether or not they have sold their investment. Investors should contact Block & Leviton to learn more.
What is Block & Leviton doing?
Block & Leviton is investigating whether the Company committed securities law violations and may file an action to attempt to recover losses on behalf of investors who have lost money.
What should you do next?
Why should you contact Block & Leviton?
Many law firms have issued releases about this matter; most of those firms do not actually litigate securities class actions. Block & Leviton is a law firm that actually litigates cases. We are dedicated to obtaining significant recoveries on behalf of defrauded investors through active litigation in the federal courts across the country. Many of the nation's top institutional investors hire us to represent their interests. You can learn more about us at our website, www.blockleviton.com, or call (617) 398-5600 or email email@example.com with any questions.
This notice may constitute attorney advertising.
SOURCE: Block & Leviton LLP
View source version on accesswire.com: